July 2026

Safety a priority as care evolves | TAVR vs. SAVR | AHA registry makes an impact | CoreMap raises $37M | Assessing genetic risk ()
Recall Roundup: Key safety updates for cardiologists & cardiac surgeons ()
FDA authorizes first AI of its kind | Custom blood vessel grafts in minutes | Murderer worked for AHA | Predicting TAVR risks ()
News Alert: FDA authorizes first AI software of its kind ()
How to prevent AFib after cardiac surgery | 2 new recalls for Medtronic | CABG device a 'breakthrough' | Surgeon makes history ()
Medtronic's new recall | AFib after cardiac surgery | Data breach leads to lawsuit | New TriClip data | FDA clears AI software ()
News Alert: Medtronic recalls thousands of devices due to risk of leaks ()
FDA shares safety warning | Radiotracer returns | Cardiologist accused of rape | Swallowed needle does damage | A new recall ()
Court case dismissed with prejudice | ChatGPT's advice nearly killed pastor, lawsuit claims | Novo Nordisk sues Eli Lilly ()
New HFpEF recommendations | ChatGPT nearly killed pastor, lawsuit claims | Opportunistic CT screening | US may be falling behind ()
Week in Review: Steerable sheaths recalled | How much coffee is safe for the heart? | Medical societies take a stand ()
Cath lab safety standards | PFA devices recalled | Getting doctors on the same page | The first robotic procedure of its kind ()
Blood clot removal device recalled | CCTA reshaping care strategies | Flu shots protect the heart | Previewing ESC Congress 2026 ()
Surgical tech hailed as a breakthrough | Cardiologist moves from ACC to Whoop | FTR after TAVR | Progress for new gene therapy ()
New device recalls | DOAC recommendations | Stereotaxis completes major acquisition | GLP-1 drugs & PAD | FDA clears AI software ()
Steerable sheaths for PFA recalled due to safety risk | Novo Nordisk sues rival Eli Lilly | Anesthesia strategies during TAVR ()
How much coffee is too much? | FDA shares an alert | Many more adults now eligible for statins | Heartflow launches staging tool ()
FDA's update on device recall | Medical societies offer feedback on major TAVR proposal | Semaglutide, weight loss & the heart ()
Top 10 most popular cardiology video interviews this past month ()
Week in Review: Heart surgeon makes history | Cardiologist's lawsuit settled | FDA OKs new cholesterol pill | CMS proposes cuts ()
News Alert: FDA now urging clinicians to return recalled vascular device ()
More payment cuts on the way? | Cardiologists want safer cath labs | Private equity in cardiology | Surgical devices recalled ()
Medtronic recalls surgical devices | FDA approves new cholesterol pill | Stereotaxis completes major acquisition | AI & TAVR ()
News Alert: FDA approves first cholesterol pill of its kind ()
CMS proposes more Medicare payment cuts | Most deaths from ischemic heart disease could have been prevented ()
Heart valve delivery system recalled | Surgeon makes history | Head-to-head TTVR study now underway | TAVR & SAVR outcomes ()
Heart surgeon makes history | Medical societies push for cath lab improvements | Patient care during cardiology conferences ()
RVU cuts in electrophysiology | Cannabis & heart disease | Breakthroughs in VT ablation | Abbott recalls heart tech ()
Predicting AKI after TAVR | New SCCT president embraces listening, teamwork | Cardiologist’s lawsuit dismissed ()
Cardiologist compensation keeps rising | AI company raises $8.5M | Family files lawsuit | Medtronic completes $550M acquisition ()
Does cannabis use cause heart disease? Cardiologists urge caution | GLP-1 drugs & PAD | AI-powered FFR tech shows potential ()
Week in Review: Medtronic recalls heart tech | AnchorMan vs. Watchman | FDA clears AI tool | Semaglutide implant on the way? ()
Confusion over new payment model | Heart failure drug recalled | 3-in-1 polypill delivers | Bad news for AstraZeneca & Ionis ()
Head-to-head TTVR study begins | New heart drug falls short in clinical trial | Cardiologist running to be Chicago's next mayor ()
Procedure kit recalls | New LAAC device compared to Watchman | Cardiologist named AHA president | Kidney injuries after PCI ()
Work underway on new semaglutide implant | FDA approves dual-energy ablation tech | Why DAPT after PCI is still a good idea ()
TAVR Highlights: CMS proposes major policy changes | Leaflet modification device impresses | New data on sex-specific outcomes ()
Quality metrics in cardiology | ACC takes on DOAC therapy | FDA approves changes for EVAR devices | Breakthroughs in VT ablation ()
Americans keep poisoning themselves | Parents charged with murder after son's death | Resistance training & heart attack risk ()
Medtronic recalls heart valve delivery system | New LAAC device put to the test | 3-in-1 polypill for heart failure impresses ()
AI company founded by cardiologist makes an impact | Cardiology a leader in FDA-cleared algorithms | New heart failure tech ()
FDA clears AI imaging tech | A close look at cardioneural ablation | Celebrating top hospitals | New TAVR device performing well ()
Week in Review: Americans keep poisoning themselves | Device recalled over safety concerns | ACC takes on antiplatelet therapies ()
AI works behind the scenes | CCTA scan delivers wake-up call | The future of FFR-CT | Subtle heart changes linked to cancer risk ()
Looking Back: Is coffee bad for the heart? | Procedure kit recalls | Cardiologist gets wake-up call | TAVR policy changes ()
Compensation still on the rise | Procedure kits recalled | A new definition of heart failure | Cardiologist named AHA president ()
New antiplatelet recommendations | Heart failure drug recalled | Imaging tech makes US debut | Conavi Medical's good news ()